Trademark: 90387118
Status Date
Monday, May 15, 2023
Filing Date
Wednesday, December 16, 2020
Published for Opposition
Tuesday, June 22, 2021
Abandoned Date
Monday, May 15, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; vaccines
May 15, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 15, 2023
Abandonment - No Use Statement Filed
Oct 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 6, 2022
Sou Extension 2 Granted
Oct 6, 2022
Sou Extension 2 Filed
Oct 6, 2022
Teas Extension Received
Apr 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2022
Sou Extension 1 Granted
Apr 4, 2022
Sou Extension 1 Filed
Apr 4, 2022
Teas Extension Received
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 12, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 1, 2021
Extension Of Time To Oppose Process - Terminated
Jul 21, 2021
Extension Of Time To Oppose Received
Jun 22, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 22, 2021
Published For Opposition
Jun 2, 2021
Notification Of Notice Of Publication E-Mailed
May 19, 2021
Approved For Pub - Principal Register
May 19, 2021
Assigned To Examiner
Feb 25, 2021
New Application Office Supplied Data Entered
Dec 19, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
